Scalene hold-relax plus conventional physical therapy for asthma
Additional Effects of Scalene Hold Relax Technique With Conventional Physical Therapy On Pulmonary Function in Asthma Patient
NA · Riphah International University · NCT07103512
This will see if adding a scalene hold-relax technique to standard physical therapy improves lung function in adults aged 20–44 with allergic asthma.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 26 (estimated) |
| Ages | 22 Years to 44 Years |
| Sex | All |
| Sponsor | Riphah International University (other) |
| Locations | 1 site (Mānsehra, Khyber PkahtoonKhwa) |
| Trial ID | NCT07103512 on ClinicalTrials.gov |
What this trial studies
Adults diagnosed with allergic asthma between ages 20 and 44 will receive conventional physical therapy, and a group will receive the scalene hold-relax technique in addition to those exercises. Pulmonary function tests will be performed before and after the intervention period to measure changes in lung function. Participants with major medical or psychological comorbidities are excluded to limit confounding factors. The intervention focuses on manual/therapeutic techniques targeting the scalene muscles as adjunctive therapy to breathing and physical therapy exercises.
Who should consider this trial
Good fit: Ideal candidates are adults aged 20–44 with a diagnosis of allergic asthma who can provide consent and participate in physical therapy sessions without major comorbidities.
Not a fit: Patients with cardiovascular disease, diabetes, other chronic illnesses, significant psychological conditions, or those outside the 20–44 age range are unlikely to benefit or are excluded from participation.
Why it matters
Potential benefit: If effective, adding the scalene hold-relax technique could improve breathing and pulmonary function and reduce asthma symptoms for participating adults.
How similar studies have performed: Manual techniques targeting accessory respiratory muscles have shown mixed and limited benefits in asthma, and the specific scalene hold-relax approach remains relatively untested in this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient diagnosed with Allergic asthma * Both male and female will be included * Age between 20 to 44 years. Exclusion Criteria: * Patient who do not provide consent * Patient with any comorbid condition such as cardiovascular disease diabetes or other chronic illness * Patient with any psychological condition that may interfere with participation or adherence to the study protocol
Where this trial is running
Mānsehra, Khyber PkahtoonKhwa
- DHQ Hospital — Mānsehra, Khyber PkahtoonKhwa, Pakistan (RECRUITING)
Study contacts
- Principal investigator: Muhammad Iqbal Tariq, PhD* — Riphah International University
- Study coordinator: Muhammad Iqbal Tariq, PhD*
- Email: iqbal.tariq@riphah.edu.pk
- Phone: +923338236752
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Asthma